|
|
|
|
| LEADER |
01168nai a2200229 u 4500 |
| 001 |
EB002202366 |
| 003 |
EBX01000000000000001339569 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
240412 r ||| eng |
| 020 |
|
|
|a 9781473153059
|
| 245 |
0 |
0 |
|a Spinal metastases and metastatic spinal cord compression
|h Elektronische Ressource
|
| 260 |
|
|
|a London
|b National Institute for Health and Care Excellence (NICE)
|c [2023]-, 2023
|
| 300 |
|
|
|a 1 online resource
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 362 |
0 |
|
|a Began in 2023
|
| 490 |
0 |
|
|a NICE clinical guidelines
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK595817
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This guideline covers recognition, referral, investigation and management of spinal metastases and metastatic spinal cord compression (MSCC). It is also relevant for direct malignant infiltration of the spine and associated cord compression. It aims to improve early diagnosis and treatment to prevent neurological injury and improve prognosis
|